The genomic and transcriptomic platforms provided by the Cancer Genomics Facility (CGF) enable a large number of diverse basic, translational, and clinical projects that fall predominantly into three research categories:
- Cancer center projects seeking to identify diagnostic biomarkers for cancer risk prediction, early detection, prognosis, and prediction of disease progression.
- Projects attempting to elaborate the underlying mechanisms of tumorigenesis in order to improve molecular classification, categorize the risk of metastasis and recurrence, and optimize therapeutic approaches.
- Studies to delineate previously unknown targets for prospective pharmacological reagents that may lead to novel therapeutic targeting strategies.
As a UPMC Hillman Cancer Center shared resource, the CGF provides a concierge service to meet the needs of the individual researcher. From tissue microdissection to the generation of sequence data.
If you have any questions or concerns, please email email@example.com.